Reckitt Benckiser to pay $1.4bn over opioid treatment sales
12-07-2019
Fed Circuit refusal paves way for Suboxone generics
05-02-2019
brianpirwin / Shutterstock.com
Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Indivior, generics, Suboxone, Dr Reddy’s, patent infringement, opioid addiction, ANDA, FDA, US Supreme Court
